NPI: 1265575591 · SANTA MARIA, CA 93454 · Specialist · NPI assigned 02/15/2007
| Authorized Official | AVERY, ROBERT (CEO) |
| NPI Enumeration Date | 02/15/2007 |
Other providers sharing the same authorized official: AVERY, ROBERT
| Provider | City | State | Total Paid |
|---|---|---|---|
| CALIFORNIA RETINA CONSULTANTS | BAKERSFIELD | CA | $17.53M |
| CALIFORNIA RETINA CONSULTANTS | OXNARD | CA | $3.52M |
| CALIFORNIA RETINA CONSULTANTS | VISALIA | CA | $327K |
| CALIFORNIA RETINA CONSULTANTS | PALMDALE | CA | $155K |
| CALIFORNIA RETINA CONSULTANTS | SAN LUIS OBISPO | CA | $140K |
| CALIFORNIA RETINA CONSULTANTS | PASO ROBLES | CA | $93K |
| CALIFORNIA RETINA CONSULTANTS | VALENCIA | CA | $97.62 |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,287 | $35K |
| 2019 | 817 | $47K |
| 2020 | 748 | $44K |
| 2021 | 1,004 | $147K |
| 2022 | 1,080 | $108K |
| 2023 | 1,291 | $140K |
| 2024 | 1,302 | $206K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 67028 | Intravitreal injection of a pharmacologic agent | 2,088 | 1,617 | $351K |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 417 | 234 | $169K |
| J2778 | Injection, ranibizumab, 0.1 mg | 414 | 232 | $151K |
| 92134 | 2,725 | 2,604 | $30K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 650 | 639 | $14K |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 778 | 751 | $6K |
| 92226 | 433 | 281 | $4K | |
| J9035 | Injection, bevacizumab, 10 mg | 24 | 13 | $2K |